Siemens Healthineers AG / DE000SHL1006

Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback – 5th Interim Reporting In the time period from and including 21 April 2025 until and including 27 April 2025, a number of 207,975 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 19 March 2025, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 24 March 2025. Shares were bought back as follows:   The transactions are published in a detailed form on the website of Siemens Healthineers AG (https://www.siemens-healthineers.com/investor-relations/share). The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 24 March 2025 until and including 27 April 2025 amounts to 3,020,885 shares. The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA). Munich, 28 April 2025 Siemens Healthineers AG The Managing Board ______________________________ 1Excluding incidental acquisition costs, rounded to four decimal places according to commercial practice.